Aigen Sciences
PrivateLast Round
Series A
Oct 16, 2024
Total Funding Raised
$11.74M
Company Overview
Aigen Sciences operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series A round in October 2024.
Aigen Sciences is a biotechnology company that provides an AI-driven drug discovery platform to develop small-molecule synthetic drugs for intractable diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aigen Sciences Comparables
Compare Aigen Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HITS Inc. | 88% | |
| PharmCADD Co., Ltd. | 88% | |
| Baobab AiBIO | 83% |
For institutional investors. Book with your work email.
Aigen Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 16, 2024 | ||||
| Pre Seed | Oct 5, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Aigen Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korea University Holdings | Pre Seed |
| K2 Investment Partners | Series A |
| Bluepoint Partners | Pre Seed |
| Premier Partners | Series A |
| QUAD Investment Management | Series A |
| Medytox Venture Investment | Pre Seed, Series A |
| Partners Investment | Pre Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Grew 33% QoQ, from 12 to 16 employees.
- Apr 19, 2026
Grew 25% QoQ, from 12 to 15 employees.
For institutional investors. Book with your work email.
Aigen Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aigen Sciences's valuation, stock price, and market status.
Is Aigen Sciences a public or private company?
Aigen Sciences is a private company.
What is the current stock price of Aigen Sciences?
Aigen Sciences is a private company, so its shares have no public market price. Caplight tracks Aigen Sciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aigen Sciences worth (valuation)?
Valuation information for Aigen Sciences is not publicly available.
Can I buy Aigen Sciences stock?
Aigen Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aigen Sciences's last funding round?
Aigen Sciences's most recent funding round was Series A on October 16, 2024.
Who are the main investors in Aigen Sciences?
Key investors in Aigen Sciences include Korea University Holdings, K2 Investment Partners, Bluepoint Partners, Premier Partners, QUAD Investment Management.
Will Aigen Sciences IPO soon?
No public IPO plans have been announced for Aigen Sciences.
How can I track Aigen Sciences secondary market activity?
Caplight tracks bids, offers, and trades in Aigen Sciences's shares on secondary markets.